National Cancer Institute; Notice of Meeting, 30316-30317 [2016-11428]
Download as PDF
asabaliauskas on DSK3SPTVN1PROD with NOTICES
30316
Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4168,
MSC 7806, Bethesda, MD 20892, (301) 435–
1726, greenbergwa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Development and Application of PET and
SPECT Imaging Ligands as Biomarkers for
Drug Discovery and for Pathophysiological
Studies of CNS Disorders (R21).
Date: June 9, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Musculoskeletal Rehabilitation Sciences
Study Section.
Date: June 10, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton BWI (Baltimore), 1100 Old
Elkridge Landing Road, Baltimore, MD
21090.
Contact Person: Maria Nurminskaya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435–1222,
nurminskayam@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function D Study Section.
Date: June 10, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: James W. Mack, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4154,
MSC 7806, Bethesda, MD 20892, (301) 435–
2037, mackj2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Enabling
Imaging Technologies.
Date: June 10, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Maria DeBernardi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7892, Bethesda, MD 20892, 301–435–
1355, debernardima@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–
345: Development of Pediatric Formulations
and Drug Delivery Systems.
VerDate Sep<11>2014
18:48 May 13, 2016
Jkt 238001
Date: June 10, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sharon S. Low, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5104, MSC 5104, Bethesda, MD
20892–5104, 301–237–1487, lowss@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 11, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11472 Filed 5–13–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biobehavior,
Inflammation, and Stress.
Date: May 19, 2016.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 11, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11473 Filed 5–13–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App. 2), notice is
hereby given of the joint meeting of the
National Cancer Advisory Board
(NCAB) and NCI Board of Scientific
Advisors (BSA).
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board; Ad Hoc Subcommittee on
Global Cancer Research.
Open: June 20, 2016, 4:30 p.m. to 6:00 p.m.
Agenda: Discussion on Global Cancer
Research.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble,
Executive Secretary, NCAB Ad Hoc
Subcommittee on Global Cancer Research,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
E:\FR\FM\16MYN1.SGM
16MYN1
Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Center Drive, Room 3W562, Bethesda, MD
20892, (240) 276–5796, trimblet@
mail.nih.gov.
Name of Committee: National Cancer
Advisory Board and Board of Scientific
Advisors.
Open: June 21, 2016, 8:00 a.m. to 4:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board, and NCI Board of
Scientific Advisors; NCI Board of Scientific
Advisors Concepts Review, NCI Acting
Director’s report.
Closed: June 21, 2016, 4:00 p.m. to 5:30
p.m.
Agenda: Review of NCAB grant
applications.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, Room 10,
9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, Room 7W444, Bethesda, MD
20892, 240–276–6340, grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
NCAB: https://deainfo.nci.nih.gov/advisory/
ncab/ncab.htm,
BSA: https://deainfo.nci.nih.gov/advisory/
bsa/bsa.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 10, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11428 Filed 5–13–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:48 May 13, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health:
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative: Foundations of NonInvasive Functional Human Brain Imaging
and Recording.
Date: June 6, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 700 F Street NW.,
Washington, DC 20001.
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Early
Phase Clinical Trials.
Date: June 7, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892–9606, 301–443–7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative: Non-Invasive
Neuromodulation—Mechanisms and Dose/
Response Relationships for Targeted CNS
Effects.
Date: June 9, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
30317
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: May 9, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11398 Filed 5–13–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; 3D Human
Tissue Culture Systems.
Date: June 14, 2016.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
2E032/034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W264, Bethesda, MD 20892–9750,
240–276–6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; R13
Conference Grants Review.
Date: June 14, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850 (Telephone
Conference Call).
E:\FR\FM\16MYN1.SGM
16MYN1
Agencies
[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Pages 30316-30317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11428]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App. 2), notice is hereby given of the joint meeting
of the National Cancer Advisory Board (NCAB) and NCI Board of
Scientific Advisors (BSA).
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
Web site (https://videocast.nih.gov).
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board; Ad Hoc
Subcommittee on Global Cancer Research.
Open: June 20, 2016, 4:30 p.m. to 6:00 p.m.
Agenda: Discussion on Global Cancer Research.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad
Hoc Subcommittee on Global Cancer Research, National Cancer
Institute--Shady Grove, National Institutes of Health, 9609 Medical
[[Page 30317]]
Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796,
trimblet@mail.nih.gov.
Name of Committee: National Cancer Advisory Board and Board of
Scientific Advisors.
Open: June 21, 2016, 8:00 a.m. to 4:00 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board, and
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors
Concepts Review, NCI Acting Director's report.
Closed: June 21, 2016, 4:00 p.m. to 5:30 p.m.
Agenda: Review of NCAB grant applications.
Place: National Institutes of Health, Building 31, C-Wing, 6th
Floor, Room 10, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, Room
7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page:
NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncab.htm,
BSA: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 10, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11428 Filed 5-13-16; 8:45 am]
BILLING CODE 4140-01-P